Название продукции:4-(Trifluoromethyl)pyridine

IUPAC Name:4-(trifluoromethyl)pyridine

CAS:3796-24-5
Молекулярная формула:C6H4F3N
Чистота:95%
Номер в каталоге:CM120878
Молекулярная масса:147.1

Упаковочная единица Доступно для заказа Цена ($) Количество
CM120878-10g in stock ǜƎƎ
CM120878-25g in stock ƎȬț
CM120878-100g in stock ǜȺȁƎ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:3796-24-5
Молекулярная формула:C6H4F3N
Точка плавления:-
Smiles-код:FC(C1=CC=NC=C1)(F)F
Плотность:
Номер в каталоге:CM120878
Молекулярная масса:147.1
Точка кипения:
Номер Mdl:MFCD00153289
Хранение:

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

Relacorilant
Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.